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Abstract 
The UK National Diabetes Inpatient COVID Response Group was formed at the end of 
March 2020 to support the provision of diabetes inpatient care during the COVID pandemic. 
It was formed in response to two emerging needs. First to ensure that basic diabetes services 
are secured and maintained at a time when there was a call for re-deployment to support the 
need for general medical expertise across secondary care services. The second was to provide 
simple safe diabetes guidelines for use by specialists and non-specialists treating inpatients 
with or suspected of COVID-19 infection. To date the group, comprising UK-based 
specialists in diabetes, pharmacy and psychology, have produced two sets of guidelines 
which will be continually revised as new evidence emerges. It is supported by Diabetes UK, 
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What’s new? 
 Diabetes specialist services help avoid unnecessary admission and readmission of 
people with diabetes to secondary care facilities and inpatient teams facilitate their 
care whilst admitted. 
 Clinicians and trainees without diabetes expertise are providing diabetes care during 
the COVID-19 pandemic. 
 This Position Statement outlines the need to maintain key elements of specialist 
diabetes services with a focus on delivering safe inpatient diabetes care. 
 The Position Statement also outlines simple pathways for the management of 
inpatients with diabetes by admitting teams in secondary care. 
 This Position Statement will be useful to trusts/health boards in redesigning clinical 
services during the COVID-19 pandemic and helping ensure that the safe care of 
people with diabetes. 
 
The COVID-19 pandemic presents the greatest challenge to healthcare delivery in living 
memory, and the impact on community and specialist diabetes services has been immense 
[1]. Many existing services have been suspended and in some areas, all diabetes staff 
(including inpatient specialist nurses) redeployed to support general inpatient care. This has 
been done at short notice and without full consideration of the important role diabetes teams 
play in preventing harm to people with diabetes, both in hospital and in the community. 
Several weeks into the pandemic, it has become increasingly apparent that support from 
inpatient diabetes specialists is essential. The management of people with diabetes who are 
acutely unwell with suspected or confirmed COVID-19 is complex [2], and many of the staff 
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systems need to be in place in the community to facilitate and support early discharge and 
prevent readmission of people with diabetes, particularly those who have been newly started 
on insulin in whom rapid dose reduction is often required. 
In the response to these challenges, the National Diabetes Inpatient COVID-19 Resource 
Group was formed in the last week of March 2020. The group comprises specialists in 
diabetes, pharmacy and psychology. To date the group have produced two sets of documents 
available on the Association of British Clinical Diabetologists and Diabetes UK web sites. 
The first set 
(https://abcd.care/sites/abcd.care/files/site_uploads/To%20the%20Diabetes%20Team_Final%
20%28004%29.docx), aimed at specialist teams and managers, outlines key service 
requirements vital to maintain patient safety while accelerating flow through the hospital. 
This is in addition to maintaining delivery of closely managed outpatient and community 
services to prevent avoidable admissions and readmissions 
(https://abcd.care/resource/maintaining-acute-diabetes-services-response-covid-19). To help 
plan services, an easy to use template based on the NHS ‘Clinical guide for the management 
of acute diabetes patients during the coronavirus pandemic’ [5], is provided as well as a 
completed template as an example of how one service has redeployed their staff 
(https://abcd.care/resource/template-defining-diabetes-services-during-covid-19-pandemic  or 
https://www.diabetes.org.uk/professionals/resources/coronavirus-clinical-guidance. 
The second three-page document, aimed at emergency departments and acute admitting 
teams provides guidance and an algorithm for diabetes management at the ‘front door’ (Fig. 
1) (https://abcd.care/resource/concise-advice-inpatient-diabetes-during-covid19-front-door-
guidance and https://www.diabetes.org.uk/professionals/resources/coronavirus-clinical-
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previously known to have diabetes may present with significant hyperglycaemia and 
therefore recommends blood glucose should be measured in all admissions. Additionally, 
anecdotal reports suggest unusual presentations of diabetic metabolic emergencies including 
people with type 2 diabetes presenting in diabetic ketoacidosis  or mixed ketoacidosis and 
hyperosmolar hyperglycaemic state. It thus recommends that ketones be checked in everyone 
with known diabetes, and those without known diabetes who present with a blood glucose 
> 12 mmol/l whether or not they are treated with sodium–glucose co-transporter 2 inhibitors. 
The document contains a table outlining key differences seen in COVID positive patients 
based on experience from UK centres with the greatest experience of looking after these 
patients. There is also brief advice on glycaemic management, blood ketone levels, insulin 
management, patients using subcutaneous pumps and finally foot care. 
The National Inpatient Diabetes COVID19 Response Group will continue to update these 
documents as more evidence becomes available, and will shortly be releasing guidance on the 
use of subcutaneous insulin for managing hyperglycaemia as well as for managing 
ketoacidosis in the event of intravenous insulin infusion pumps being unavailable because of 
increased demands for use to deliver other therapies. The group is also continuing to work on 
patient-facing resources to support preparation for any potential hospital admission, and safe 
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